IPO of Brainlab: A Milestone for Medical Technology
The Munich-based medical technology company Brainlab is preparing for its IPO on the Frankfurt Stock Exchange in the coming weeks. The IPO is expected to take place between late June and early July 2025. This will be the largest German IPO and the third largest in Europe this year.
About Brainlab
Brainlab specializes in software-assisted surgery and offers advanced navigation systems for surgeries on the brain, tumors, the spine, nerve pathways, and for the treatment of epilepsy. Their technology also improves precision in radiation therapy for oncology. Company founder Stefan Vilsmeier describes the innovation as “Google Maps for surgery,” using the individual anatomy of a patient as a map to guide surgeons during procedures.
Goals of the IPO
The IPO aims to raise about 600 million euros through new and existing shares, thereby valuing Brainlab at around 3 billion euros. The capital raised is intended to support business growth, focusing on the expansion of clinical applications and strengthening the company’s financial position.
Key IPO Details
- Listing: Regulated Market of the Frankfurt Stock Exchange (Prime Standard)
- Start of Bookbuilding: June 23, 2025
- Joint Global Coordinators: Berenberg and Deutsche Bank
- Joint Bookrunners: Commerzbank, Jefferies, UniCredit/Kepler Cheuvreux
- Company Size: About 2,000 employees
- Customer Base: Approximately 4,000 hospitals worldwide
Brainlab’s upcoming IPO signifies not only a significant milestone for the company itself but also for the German medical technology sector. The funds raised are intended to accelerate the digital transformation in healthcare through enhanced product development and global reach.